Physicians and researchers present groundbreaking findings from late-breaking clinical trials, follow-up data from major randomized trials and registries, and first-in-man experiences with novel devices or drugs. Each presentation is followed by a discussion and Q&A with a panel of expert faculty.
Important 2024 Dates
VIVA and The VEINS embargo Late-Breaking Clinical Trial information from becoming public until after the commencement of the session as listed in the conference program or on viva-foundation.org. No publication, exhibitor, or affiliated company may disseminate information until after the commencement of the Late-Breaking Clinical Trial session in which it is presented.
Abstracts will be evaluated and scored based on the following criteria:
Accepted late-breaking clinical trials will be presented:
The review committee may determine that your abstract may be more appropriate for a different session or conference than you originally submitted.
If you have questions please contact Brita Thorne via e-mail: abstracts@viva-foundation.org
